Clinical Trial Update: L-carnosine Prophylactic Effect on Oxaliplatin Induced Peripheral Neuropathy in GIT Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial at Cairo University evaluated whether prophylactic L-carnosine can reduce oxaliplatin-induced peripheral neuropathy in pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer
• Peripheral Neuropathy

Drugs mentioned

• L-carnosine (L-carnosine)

Snippet

Sponsor: Cairo University | Conditions: Peripheral Neuropathy, Cancer | Phase 1, Phase 2 | Status: COMPLETED